Skip Navigation
Menu
Ideas and Opinions |21 August 2018

Brief Commentary: Glycemic Targets for Older Adults With Type 2 Diabetes

Emily B. Schroeder, MD, PhD; Andrew J. Karter, PhD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 26 June 2018.
  • Kaiser Permanente Colorado and University of Colorado, Aurora, Colorado (E.B.S.)
    Kaiser Permanente Northern California, Oakland, California (A.J.K.)

    Grant Support: Dr. Schroeder is supported by grants K23 DK099237 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and R01 HS022963 from the Agency for Healthcare Research and Quality. Dr. Karter is supported by grants P30 DK092924 and R01 DK103721 from NIDDK, R56 AG051683 from the National Institute on Aging, R01 LM012355 from the National Library of Medicine, and BAA-13-00119 from the U.S. Food and Drug Administration.

    Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-1471.

    Corresponding Author: Emily B. Schroeder, MD, PhD, Institute for Health Research, Kaiser Permanente Colorado, 2550 South Parker Road, Suite 200, Aurora, CO 80014; e-mail, emily.b.schroeder@kp.org.

    Current Author Addresses: Dr. Schroeder: Institute for Health Research, Kaiser Permanente Colorado, 2550 South Parker Road, Suite 200, Aurora, CO 80014.

    Dr. Karter: Division of Research, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612.

    Author Contributions: Conception and design: E.B. Schroeder.

    Drafting of the article: E.B. Schroeder.

    Critical revision for important intellectual content: E.B. Schroeder, A.J. Karter.

    Final approval of the article: E.B. Schroeder, A.J. Karter.

×
FULL TEXT
This article has been corrected. The original version (PDF) is appended to this article as a Supplement.
Editors' Note: This commentary was selected for publication from among several submitted in response to a call for readers' perspectives on treatment targets for type 2 diabetes.
Most guidelines recommend individualizing glycemic targets for patients with type 2 diabetes in the context of shared decision making (1–4). In general, this strategy weighs the benefits of treatment against such factors as age, life expectancy, disease complexity, functional and cognitive impairments, risk for adverse drug effects, medication burden, and available resources. Despite the aligned goals of maximizing treatment benefit and safety, organizations have reached different conclusions regarding optimal hemoglobin A1c (HbA1c) targets for older adults with type 2 diabetes.
The American Diabetes Association provides 2 frameworks (1, 2). The first determines how stringent an HbA1c target to pursue on the basis of a list of patient features. The second categorizes older adults into 3 groups (healthy, complex or intermediate, and very complex or poor health), each with a corresponding HbA1c target (<7.5%, <8.0%, and <8.5%). The American Diabetes Association does not recommend HbA1c targets higher than 8.5% because of the “acute risks from glycosuria, dehydration, hyperglycemic hyperosmolar syndrome, and poor wound healing” (2). In contrast, the U.S. Department of Veterans Affairs and Department of Defense outlines a 3 × 3 table of major comorbid conditions, life expectancy, and absence or presence...
FULL TEXT
PDF
Not Available
Citations
Citation

Schroeder EB, Karter AJ. Brief Commentary: Glycemic Targets for Older Adults With Type 2 Diabetes. Ann Intern Med. 2018;169:250–251. [Epub ahead of print 26 June 2018]. doi: https://doi.org/10.7326/M18-1471

Download citation file:

© 2020

×
Permissions

Published: Ann Intern Med. 2018;169(4):250-251.

DOI: 10.7326/M18-1471

Published at www.annals.org on 26 June 2018

©
2018 American College of Physicians
2 Citations

Related Articles
Annals for Educators - 7 November 2017
Annals of Internal Medicine; 167 (9): ED9
Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer
Annals of Internal Medicine; 151 (12): JC6-14
Use of antipsychotic drugs was associated with increased risk for hyperglycemia in older patients with diabetes
Annals of Internal Medicine; 151 (10): JC5-12
The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis
Annals of Internal Medicine; 149 (1): 11-19
View MoreView Less

Journal Club
Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer
Annals of Internal Medicine; 151 (12): JC6-14
Use of antipsychotic drugs was associated with increased risk for hyperglycemia in older patients with diabetes
Annals of Internal Medicine; 151 (10): JC5-12
Thiazolidinediones increased risk for heart failure, myocardial infarction, and death in older patients with type 2 diabetes
Annals of Internal Medicine; 148 (12): JC4-13
In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes
Annals of Internal Medicine; 172 (4): JC18
View MoreView Less

Related Point of Care
Type 2 Diabetes
Annals of Internal Medicine; 171 (9): ITC65-ITC80
Fall Prevention in Community-Dwelling Older Adults
Annals of Internal Medicine; 169 (11): ITC81-ITC96
Type 2 Diabetes
Annals of Internal Medicine; 162 (5): ITC1
Type 2 Diabetes
Annals of Internal Medicine; 152 (5): ITC3-1
View MoreView Less

Related Topics
Cardiology
Coronary Risk Factors
Diabetes
Endocrine and Metabolism
Geriatric Medicine

Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Geriatric Medicine.

PubMed Articles
The beneficial effects of Agaricus blazei Murrill on hepatic antioxidant enzymes and the pancreatic tissue recovery in streptozotocin-induced diabetic rats.
J Food Biochem 2020.
Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-Analysis.
Am J Nephrol 2020.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×